It’s been a whirlwind of news about pop peptides like BPC-157 and now one of the first indictments related to marketing of these unproven drugs at a clinic. While RFK Jr. may want to unleash previously banned peptides on the public, it hasn’t happened yet. Those still selling these unproven peptides anyway have had to […]
RFK Jr. might be the biggest peptides fan of all. Or it could be the compounding pharmacy industry or Joe Rogan. For a few years, compounders were profiting from marketing the most popular of these unproven peptide drugs (what I call “pop peptides”). The FDA put a halt to that in 2023. The agency at
RFK Jr. posted last year about wanting to weaken FDA oversight of both stem cells and peptides. What we mean by peptides here is a class of unproven and non-FDA-approved drugs sold by wellness influencers. Compounding pharmacies have made such wellness peptides available in the past before the FDA rightly became more restrictive about their
GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC-157 Read More »
Last year, HHS Secretary RFK Jr. claimed in a post that the FDA was suppressing things like peptides and stem cells. I started hearing about “peptides” earlier, about 2-3 years ago. Some were saying that specific peptides were even better than stem cells, which is a big red flag. The term “peptides” in this context
Peptides like BPC-157 and other related regenerative compounds have surged in popularity, but scientific evidence and regulatory oversight remain limited. This article examines the science and policy on BPC-157. Overall, there aren’t many data out there from strong clinical trials. Even so, RFK Jr. claimed that the FDA was suppressing useful peptides. He mentioned this
RFK Jr. & claimed regenerative peptides like BPC-157 Read More »